Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Dec 16, 2019 | Option/RSU Exercise | $1.81 | 8,000 | 14,480 | 172,320 | Dec 18, 2019, 04:05 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Dec 01, 2019 | Tax Payment (Shares) | $71.65 | 741 | 53,093 | 164,320 | Dec 02, 2019, 05:12 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Sep 01, 2019 | Tax Payment (Shares) | $46.21 | 740 | 34,195 | 165,061 | Sep 03, 2019, 04:23 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Jun 17, 2019 | Option/RSU Exercise | $1.81 | 20,000 | 36,200 | 185,801 | Jun 19, 2019, 04:15 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Jun 17, 2019 | Sale | $46.00 | 20,000 | 920,000 | 165,801 | Jun 19, 2019, 04:15 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Jun 01, 2019 | Tax Payment (Shares) | $35.57 | 741 | 26,357 | 165,801 | Jun 04, 2019, 04:25 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Apr 29, 2019 | Sale | $42.03 | 20,000 | 840,600 | 166,542 | May 01, 2019, 04:05 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Apr 29, 2019 | Option/RSU Exercise | $1.81 | 20,000 | 36,200 | 186,542 | May 01, 2019, 04:05 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Mar 01, 2019 | Tax Payment (Shares) | $39.97 | 748 | 29,898 | 166,542 | Mar 05, 2019, 05:57 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Dec 07, 2018 | Option/RSU Exercise | $1.81 | 21,500 | 38,915 | 167,290 | Dec 11, 2018, 04:29 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Dec 01, 2018 | Tax Payment (Shares) | $38.33 | 741 | 28,403 | 145,790 | Dec 03, 2018, 05:29 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Sep 01, 2018 | Tax Payment (Shares) | $56.67 | 741 | 41,992 | 146,531 | Sep 04, 2018, 06:33 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Jun 01, 2018 | Option/RSU Exercise | $1.81 | 15,000 | 27,150 | 163,560 | Jun 05, 2018, 08:20 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Jun 01, 2018 | Sale | $69.36 | 15,000 | 1,040,400 | 158,960 | Jun 05, 2018, 08:20 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Jun 04, 2018 | Tax Payment (Shares) | $67.13 | 741 | 49,743 | 147,819 | Jun 05, 2018, 08:20 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Dec 21, 2017 | Option/RSU Exercise | $1.81 | 15,000 | 27,150 | 148,560 | Dec 26, 2017, 05:11 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Executive Officer | Dec 01, 2017 | Award/Grant | $19.12 | 26,667 | 509,873 | 133,560 | Dec 05, 2017, 04:19 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Aug 30, 2017 | Sale | $20.00 | 4,000 | 80,000 | 106,893 | Aug 30, 2017, 06:12 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Aug 28, 2017 | Sale | $20.09 | 23,154 | 465,162 | 110,893 | Aug 30, 2017, 06:12 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 26, 2017 | Option/RSU Exercise | $1.81 | 3,275 | 5,928 | 137,322 | Apr 28, 2017, 06:13 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 26, 2017 | Sale | $16.74 | 3,275 | 54,816 | 134,047 | Apr 28, 2017, 06:13 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 27, 2017 | Option/RSU Exercise | $1.81 | 2,206 | 3,993 | 136,253 | Apr 28, 2017, 06:13 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 27, 2017 | Sale | $16.78 | 2,206 | 37,023 | 134,047 | Apr 28, 2017, 06:13 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 21, 2017 | Sale | $17.01 | 3,000 | 51,033 | 134,047 | Apr 25, 2017, 07:36 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 24, 2017 | Option/RSU Exercise | $1.81 | 3,500 | 6,335 | 137,547 | Apr 25, 2017, 07:36 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 24, 2017 | Sale | $16.46 | 3,500 | 57,619 | 134,047 | Apr 25, 2017, 07:36 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 25, 2017 | Option/RSU Exercise | $1.81 | 5,115 | 9,258 | 139,162 | Apr 25, 2017, 07:36 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 25, 2017 | Sale | $16.87 | 5,115 | 86,290 | 134,047 | Apr 25, 2017, 07:36 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 21, 2017 | Option/RSU Exercise | $1.81 | 3,000 | 5,430 | 137,047 | Apr 25, 2017, 07:36 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 19, 2017 | Option/RSU Exercise | $1.81 | 7,258 | 13,137 | 141,305 | Apr 21, 2017, 04:32 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 19, 2017 | Sale | $17.88 | 7,258 | 129,754 | 136,496 | Apr 21, 2017, 04:32 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 20, 2017 | Option/RSU Exercise | $1.81 | 2,800 | 5,068 | 136,847 | Apr 21, 2017, 04:32 PM | |
CRSP | CRISPR Therapeutics AG | Samarth Kulkarni | Chief Business Officer | Apr 20, 2017 | Sale | $17.36 | 2,800 | 48,621 | 134,047 | Apr 21, 2017, 04:32 PM |